Virbac (OTC:VRBCF) Trading Down 10.6% – Time to Sell?

Virbac SA (OTC:VRBCFGet Free Report) shares traded down 10.6% during mid-day trading on Friday . The stock traded as low as $341.34 and last traded at $341.34. 100 shares were traded during mid-day trading, an increase of 0% from the average session volume of 100 shares. The stock had previously closed at $382.00.

Virbac Stock Performance

The company’s 50-day moving average price is $341.84 and its 200-day moving average price is $363.09.

Virbac Company Profile

(Get Free Report)

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification.

Read More

Receive News & Ratings for Virbac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virbac and related companies with MarketBeat.com's FREE daily email newsletter.